CX Institutional raised its stake in MetLife, Inc. (NYSE:MET – Free Report) by 15.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 68,005 shares of the financial services provider’s stock after purchasing an additional 9,337 shares during the quarter. CX Institutional’s holdings in MetLife were worth $5,568,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. MeadowBrook Investment Advisors LLC grew its position in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares during the period. Carmichael Hill & Associates Inc. grew its holdings in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC increased its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife in the third quarter valued at approximately $30,000. Finally, Retirement Wealth Solutions LLC bought a new position in shares of MetLife during the 4th quarter worth approximately $32,000. Institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
Several research firms have commented on MET. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Jefferies Financial Group raised their price objective on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. BMO Capital Markets started coverage on MetLife in a research note on Thursday. They set a “market perform” rating and a $97.00 target price on the stock. Piper Sandler upped their price objective on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Finally, TD Cowen upped their price target on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.46.
MetLife Stock Performance
NYSE MET opened at $87.30 on Friday. MetLife, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $89.05. The stock has a market cap of $60.45 billion, a PE ratio of 17.61, a PEG ratio of 0.65 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The firm’s fifty day moving average price is $83.68 and its two-hundred day moving average price is $79.82.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.50%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s payout ratio is 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What is the NASDAQ Stock Exchange?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- What is a support level?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Ride Out The Recession With These Dividend KingsĀ
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.